Kimman G P, Bogaard M D, van Hemel N M, van Dessel P F H M, Jessurun E R, Boersma L V A, Wever E F D, Theuns D A M J, Jordaens L J
Department of Cardiology, Medical Centre Alkmaar, Alkmaar, The Netherlands.
Pacing Clin Electrophysiol. 2005 Dec;28(12):1302-9. doi: 10.1111/j.1540-8159.2005.00271.x.
Radiofrequency (RF) catheter ablation is highly effective with a low complication rate. However, lesions created by RF energy are irreversible, inhomogeneous, and therefore potentially proarrhythmic.
The aim of this study was to examine the magnitude and importance of long-term proarrhythmic effects of RF energy.
Between 1991 and 1995, 120 patients underwent RF ablation for atrioventricular nodal reentrant tachycardia (AVNRT). Patient data were collected by contacting patients and/or filling out a questionnaire, and medical files were screened for recurrent, documented arrhythmias, pharmacological treatment, and repeated EP study. Referring cardiologists were asked about recurrences of tachyarrhythmias. Fourteen patients (11%) were lost to follow-up. During a mean follow-up of 10 years, six patients died. Recurrences of AVNRT were not any more observed after 3 years after ablation. A total of 29 patients (24%) suffered from new arrhythmias, 6 from type 1 atrial flutter, 6 from atrial tachycardia, 9 from atrial fibrillation, and finally 16 from symptomatic premature atrial contractions (PACs), needing medical treatment or a combination of these arrhythmias. Nine patients underwent pacemaker implantation, 4 after developing procedural atrioventricular (AV) conduction disturbances, 2 after His ablation for permanent atrial fibrillation, 1 patient for sick sinus syndrome, and another 2 patients after developing late AV block, respectively, 7 and 9 years after ablation.
During long-term follow-up after RF ablation for AVNRT, no AVNRT recurrences were observed, but 29 patients (24%) suffered from new arrhythmias or late AV block. This potential proarrhythmic effect of RF energy promotes the application of alternative energy sources for ablative therapies for cardiac arrhythmias.
射频(RF)导管消融术疗效显著且并发症发生率低。然而,射频能量产生的损伤是不可逆的、不均匀的,因此可能导致心律失常。
本研究旨在探讨射频能量长期致心律失常效应的程度及重要性。
1991年至1995年间,120例患者接受了房室结折返性心动过速(AVNRT)的射频消融治疗。通过联系患者和/或填写问卷收集患者数据,并筛查医疗档案以了解复发性、有记录的心律失常、药物治疗及重复的电生理研究情况。向转诊的心脏病专家询问快速性心律失常的复发情况。14例患者(11%)失访。平均随访10年期间,6例患者死亡。消融术后3年未再观察到AVNRT复发。共有29例患者(24%)出现新的心律失常,6例为1型心房扑动,6例为房性心动过速,9例为心房颤动,最后16例为有症状的房性早搏(PAC),需要药物治疗或这些心律失常的组合治疗。9例患者接受了起搏器植入,4例在发生手术相关的房室(AV)传导障碍后植入,2例在因永久性心房颤动进行希氏束消融后植入,1例因病态窦房结综合征植入,另外2例在消融后7年和9年分别发生晚期AV阻滞时植入。
在AVNRT射频消融术后的长期随访中,未观察到AVNRT复发,但29例患者(24%)出现了新的心律失常或晚期AV阻滞。射频能量的这种潜在致心律失常效应促使人们将替代能量源应用于心律失常的消融治疗。